Claire E. O’Hanlon is an adjunct policy researcher at the RAND Corporation. O’Hanlon is a health services, economics, and policy researcher experienced in applied quantitative, qualitative, and mixed methods. Her research interests include health care markets, aging and the end of life, and emerging health technologies. She will begin a postdoctoral fellowship in health services research at the Veterans Affairs Center for the Study of Healthcare Innovation, Implementation & Policy in Los Angeles in September 2018.
During her doctoral studies, she worked as an assistant policy researcher at RAND and served as a student liaison for RAND Health. O’Hanlon has previously worked in health economics and outcomes modeling at Amgen, University of Chicago Medicine, and Knopp Biosciences, a biotechnology start-up. Prior to her graduate studies, O’Hanlon was a laboratory technician at Duquesne University, where she designed drug delivery agents. O’Hanlon holds a doctorate in policy analysis from the Pardee RAND Graduate School, a Master of Public Policy from the University of Chicago Harris School, a certificate in health administration and policy from the University of Chicago, and a B.S. in engineering from Harvey Mudd College.
O’Hanlon CE, Parthan A, Kruse M, Cartier S, Stollenwerk B, Jiang Y, Caloyeras J, Crittenden DB, Barron R, "A model for assessing the clinical and economic benefits of bone-forming osteoporosis agents in reducing fractures in post-menopausal women at high, near-term risk of fragility fracture," Clinical Therapeutics, 0, 2017
Mullins L, O’Hanlon CE, Shadel W, Tucker JS, "A qualitative study of smoking cessation experiences and perceptions among homeless young adults," Journal of Social Distress and the Homeless, 0, 2017
Chari R, O’Hanlon C, Chen P, Leuschner K, Nelson C, "Governing academic medical center systems: evaluating and choosing among alternative governance approaches," Academic Medicine, 0, 2017
O’Hanlon CE, Cooper JM, Lee SM, John P, Churpek M, Chin MH, Huang ES, "Life expectancy predictions for older diabetic patients as estimated by physicians and a prognostic model," Medical Decision Making Policy & Practice, 0, 2017
O’Hanlon C, Huang C, Sloss E, Anhang Price R, Hussey P, Farmer C, Gidengil C, "Comparing VA and non-VA quality of care: a systematic review," Journal of General Internal Medicine, 0, 2016
O'Hanlon CE, Newberry SJ, Booth M, Grant S, Motala A, Maglione MA, FitzGerald JD, Shekelle PG, "Hyaluronic acid injection therapy for osteoarthritis of the knee: concordant efficacy and conflicting serious adverse events in two systematic reviews," Systematic Reviews, 0, 2016
Linnemayr SG, O’Hanlon CE, Uscher-Pines L, Van Abel K, Nelson C, "Using insights from behavioral economics to strengthen disaster preparedness and response," Disaster Medicine and Public Health Preparedness, 0, 2016
O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM, "NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging," Journal of Fluorine Chemistry, 0, 2012